中东和非洲脑癌诊断市场预测至 2028 年 - COVID-19 影响和按诊断类型（影像测试、腰椎穿刺、活检、分子测试等）进行的区域分析；癌症类型（听神经瘤、星形细胞瘤、颅咽管瘤、神经节神经瘤、多形性胶质母细胞瘤、脑膜瘤、室管膜瘤等）；最终用户（医院、专科诊所、门诊手术中心等）
市场介绍
脑癌是由于大脑中导致肿瘤的细胞在细胞外生长而引起的。肿瘤包括原发性脑肿瘤和继发性脑肿瘤。原发性脑肿瘤在大脑中形成，不会扩散到身体其他部位，而继发性肿瘤，也称为转移瘤，是那些始于身体其他部位的癌症。脑肿瘤分为40种主要类型，进一步分为两大类，包括良性（即生长缓慢且不易扩散）和恶性（即癌变且更容易扩散）。
< p>因此，脑癌患病率的增加预计将在未来几年对脑癌诊断产生巨大需求，预计这将进一步推动脑癌诊断市场的发展。疫情已导致全世界的卫生服务受到干扰，并影响了各国处理和应对脑癌等危重疾病的能力。在许多国家，诊断服务受到干扰，关键商品的供应链已经捉襟见肘。在非洲，COVID-19 威胁到了包括脑癌在内的主要健康状况的控制。随着 COVID-19 继续在非洲传播，人们担心其对市场的影响、诊断有限以及接触专家神经外科医生的机会减少，进一步影响该地区的市场。然而，随着疫情的结束，对脑癌诊断中使用的多种诊断方式的需求将会增加。
< p>市场概况和动态
中东和非洲的脑癌诊断市场预计将从 2021 年的 8740 万美元增长到美国到 2028 年将达到 2.37 亿美元；预计 2021 年至 2028 年复合年增长率为 15.3%。“原发性脑肿瘤”一词是指始于大脑的肿瘤。脑部和神经系统癌症是男性和女性第十大死因。在人的一生中，患这种肿瘤的几率不到 1%。大多数原发性中枢神经系统 (CNS) 恶性肿瘤是脑肿瘤，占所有病例的 85% 至 90%。脑肿瘤可能致命，严重影响生活质量，并最终改变患者及其家人的生活。此外，肿瘤的早期发现通常可以提供更多的治疗选择。先进的成像技术可以精确定位脑肿瘤的位置。诊断工具包括磁共振成像 (MRI) 和计算机断层扫描（CT 或 CAT 扫描）。术中 MRI 还可用于指导手术期间的组织活检和肿瘤切除。磁共振波谱（MRS）用于检查肿瘤的化学特征。因此，脑癌患病率的增加迫切需要脑癌诊断工具。
主要细分市场
方面从诊断类型来看，2020年影像测试细分市场在中东和非洲脑癌诊断市场中占据最大份额。 从癌症类型来看，多形性胶质母细胞瘤细分市场在中东和非洲脑癌诊断市场中占据最大份额2020年市场。就最终用户而言，医院细分市场在2020年中东和非洲脑癌诊断市场中占据最大份额。
主要来源和上市公司
准备本报告时参考的一些主要一手和二手来源中东和非洲脑癌诊断市场上的信息包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司包括 Thermo Fisher Scientific Inc.、Siemens Healthineers A、GE Healthcare、Biocept, Inc.、Koninklijke Philips NV、Canon Medical Systems、Hitachi, Ltd. 和 Neusoft Medical Systems。
原因购买报告
- 了解中东和非洲脑癌诊断市场格局并确定最有可能的细分市场保证丰厚的回报
- 了解中东和非洲脑癌诊断市场不断变化的竞争格局，保持领先地位
- 有效规划中东地区的并购和合作交易东非脑癌诊断市场通过确定最有前景的可能销售细分市场
- 通过对中东和非洲脑癌诊断市场各个细分市场的市场表现进行敏锐和全面的分析，帮助做出明智的业务决策
- 获取中东和非洲地区2021-2028年各细分市场的市场收入预测。
中东和非洲脑癌诊断市场细分
按诊断类型
- 影像检查
- MRI
- CT扫描
- PET
- 活检
- 分子检测
- 腰椎穿刺
- 其他
按癌症类型
- 多形性胶质母细胞瘤
- 星形细胞瘤
- 室管膜瘤
- 其他
由最终用户
- 医院
- 专科诊所
- 门诊手术中心
- 其他
按国家/地区
- 中东和非洲
- 阿联酋
- 沙特阿拉伯
- 南非
- 中东和非洲其他地区
强> 提及的公司
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Brain Cancer Diagnostics Market – By Diagnostic Type
1.3.2 Brain Cancer Diagnostics Market – By Cancer Type
1.3.3 Brain Cancer Diagnostics Market – By End User
1.3.4 Middle East and Africa Brain Cancer Diagnostics Market – By Country
2. Middle East and Africa Brain Cancer Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East and Africa Brain Cancer Diagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Brain Cancer Diagnostics Market- Middle East and Africa PEST Analysis
4.3 Expert Opinion
5. Middle East and Africa Brain Cancer Diagnostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Prevalence of Brain Cancer
5.1.2 Rise in Number of Cigarette Smokers
5.2 Market Restraints
5.2.1 High Cost of Diagnosis
5.3 Future Trends
5.3.1 Use of Stimulated Raman Histology (SRH)?Artificial Intelligence (AI) to Enhance Brain Tumor Diagnosis During Surgery
5.4 Impact Analysis
6. Brain Cancer Diagnostics Market – Middle East and Africa Analysis
6.1 Middle East and Africa Brain Cancer Diagnostics Market Revenue Forecasts and Analysis
7. Middle East and Africa Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Diagnostic Type
7.1 Overview
7.2 Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)
7.3 Imaging Tests
7.3.1 Overview
7.3.2 Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 MRI
7.3.3.1 Overview
7.3.3.2 MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 CT Scan
7.3.4.1 Overview
7.3.4.2 CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Positron emission tomography (PET)
7.3.5.1 Overview
7.3.5.2 Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Lumbar Puncture
7.4.1 Overview
7.4.2 Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Biopsy
7.5.1 Overview
7.5.2 Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Molecular Testing
7.6.1 Overview
7.6.2 Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8. Middle East and Africa Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Cancer Type
8.1 Overview
8.2 Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)
8.3 Astrocytomas
8.3.1 Overview
8.3.2 Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Glioblastoma Multiforme
8.4.1 Overview
8.4.2 Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Ependymomas
8.5.1 Overview
8.5.2 Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. Brain Cancer Diagnostics Market Analysis – By End user
9.1 Overview
9.2 Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Specialty Clinics
9.4.1 Overview
9.4.2 Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10. Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis
10.1 Middle East and Africa: Brain Cancer Diagnostics Market
10.1.1 Overview
10.1.2 Middle East and Africa: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
10.1.2.1 Saudi Arabia: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 Saudi Arabia: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.2 Saudi Arabia Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2.1 Saudi Arabia Brain Cancer Diagnostics Market, by Imaging Test– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3 Saudi Arabia Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.4 Saudi Arabia Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
10.1.2.2 UAE: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 UAE: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.2 UAE Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2.1 UAE Brain Cancer Diagnostics Market, by Imaging Test– Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3 UAE Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.2.4 UAE Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
10.1.2.3 South Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 South Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.2 South Africa Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2.1 South Africa Brain Cancer Diagnostics Market, by Imaging Test– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3 South Africa Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.4 South Africa Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
10.1.2.4 Rest of Middle East and Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.1 Rest of Middle East and Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.2 Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.4.2.1 Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
10.1.2.4.3 Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.4.4 Rest of Middle East and Africa Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
11. Impact Of COVID-19 Pandemic on Middle East and Africa Brain Cancer Diagnostics Market
11.1 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.1 Organic Developments
12.1.1 Overview
12.2 Inorganic Developments
12.2.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Siemens Healthineers AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 GE Healthcare
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Biocept, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Koninklijke Philips N.V.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Canon Medical Systems
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Hitachi, Ltd.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Neusoft Medical Systems
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Saudi Arabia Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)
Table 2. Saudi Arabia Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
Table 3. Saudi Arabia Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 4. Saudi Arabia Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 5. UAE Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)
Table 6. UAE Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
Table 7. UAE Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 8. UAE Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 9. South Africa Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)
Table 10. South Africa Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
Table 11. South Africa Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 12. South Africa Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 13. Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)
Table 14. Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
Table 15. Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 16. Rest of Middle East and Africa Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 17. Organic Developments in the Brain Cancer Diagnostics Market
Table 18. Inorganic Developments in the Brain Cancer Diagnostics Market
Table 19. Glossary of Terms, Brain Cancer Diagnostics Market
LIST OF FIGURES
Figure 1. Brain Cancer Diagnostics Market Segmentation
Figure 2. Middle East and Africa Brain Cancer Diagnostics Market Overview
Figure 3. Imaging Test Segment Held Largest Share of Diagnostic Type in Brain Cancer Diagnostics Market
Figure 4. Saudi Arabia is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Brain Cancer Diagnostics Market - Middle East and Africa PEST Analysis
Figure 6. Brain Cancer Diagnostics Market Impact Analysis of Driver and Restraints
Figure 7. Middle East and Africa Brain cancer diagnostics Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 8. Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)
Figure 9. Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)
Figure 18. Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)
Figure 23. Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Middle East and Africa: Brain Cancer Diagnostics Market, by Key Country – Revenue (2021) (USD Million)
Figure 28. Middle East and Africa: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 29. Saudi Arabia: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
Figure 30. UAE: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
Figure 31. South Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
Figure 32. Rest of Middle East and Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
Figure 33. Impact of COVID-19 Pandemic in Middle East and African Country Markets
Figure 34. Growth Strategies Done by the Companies in the Market, (%)
- Thermo Fisher Scientific Inc.
- Siemens Healthineers A
- GE Healthcare
- Biocept, Inc.
- Koninklijke Philips N.V
- Canon Medical Systems
- Hitachi, Ltd.
- Neusoft Medical Systems
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East and Africa brain cancer diagnostics market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East and Africa brain cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Middle East and Africa market trends and outlook coupled with the factors driving the brain cancer diagnostics market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution